发明公开
- 专利标题： NOVEL INHIBITORS OF HEPATITIS C VIRUS
- 专利标题（中）： 新的丙型肝炎病毒抑制剂
-
申请号： EP11784875.4申请日： 2011-11-03
-
公开(公告)号： EP2635571A1公开(公告)日： 2013-09-11
- 发明人: MCKINNELL, Robert Murray , LONG, Daniel D. , VAN ORDEN, Lori Jean , JIANG, Lan , LOO, Mandy , SAITO, Daisuke Roland , ZIPFEL, Sheila , STANGELAND, Eric L. , LEPACK, Kassandra , OGAWA, Gavin , HUANG, Xiaojun , ZHANG, Weijiang
- 申请人： Theravance, Inc.
- 申请人地址： 901 Gateway Boulevard South San Francisco, CA 94080 US
- 专利权人： Theravance, Inc.
- 当前专利权人： Theravance, Inc.
- 当前专利权人地址： 901 Gateway Boulevard South San Francisco, CA 94080 US
- 代理机构： Scott, Susan Margaret
- 优先权： US201161492267P 20110601; US201161444046P 20110217; US410267P 20101104
- 国际公布： WO2012061552 20120510
- 主分类号： C07D403/14
- IPC分类号： C07D403/14 ; A61K31/4025 ; A61K31/12
摘要：
The invention provides compounds of formula (I) wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds.
公开/授权文献
- EP2635571B1 NOVEL INHIBITORS OF HEPATITIS C VIRUS 公开/授权日：2015-08-12
信息查询
